Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.
2.

Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells.

Pagès F, Galon J, Karaschuk G, Dudziak D, Camus M, Lazar V, Camilleri-Broët S, Lagorce-Pagès C, Lebel-Binay S, Laux G, Fridman WH, Henglein B.

Blood. 2005 Feb 15;105(4):1632-9. Epub 2004 Oct 21.

PMID:
15498855
3.

Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.

Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, Thimmapaya B, Pestell RG.

J Biol Chem. 1999 Nov 26;274(48):34186-95.

4.

Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance.

Pagès F, Berger A, Henglein B, Piqueras B, Danel C, Zinzindohoue F, Thiounn N, Cugnenc PH, Fridman WH.

Int J Cancer. 1999 Jun 21;84(3):326-30.

5.

Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.

Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG.

Mol Cell Biol. 1998 Jun;18(6):3212-22.

6.

p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression.

Zerfass-Thome K, Schulze A, Zwerschke W, Vogt B, Helin K, Bartek J, Henglein B, Jansen-Dürr P.

Mol Cell Biol. 1997 Jan;17(1):407-15.

7.

A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays.

Porrás A, Bennett J, Howe A, Tokos K, Bouck N, Henglein B, Sathyamangalam S, Thimmapaya B, Rundell K.

J Virol. 1996 Oct;70(10):6902-8.

8.

Anchorage-dependent transcription of the cyclin A gene.

Schulze A, Zerfass-Thome K, Bergès J, Middendorp S, Jansen-Dürr P, Henglein B.

Mol Cell Biol. 1996 Sep;16(9):4632-8.

9.

Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.

Rudolph B, Saffrich R, Zwicker J, Henglein B, Müller R, Ansorge W, Eilers M.

EMBO J. 1996 Jun 17;15(12):3065-76.

10.

Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107.

Zerfass K, Spitkovsky D, Schulze A, Joswig S, Henglein B, Jansen-Dürr P.

J Virol. 1996 Apr;70(4):2637-42.

11.

Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.

Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Bergès J, Helin K, Jansen-Dürr P, Henglein B.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11264-8.

12.

TGF-beta 1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways.

Barlat I, Henglein B, Plet A, Lamb N, Fernandez A, McKenzie F, Pouysségur J, Vié A, Blanchard JM.

Oncogene. 1995 Oct 5;11(7):1309-18.

PMID:
7478551
13.

Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation.

Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Dürr P.

J Virol. 1995 Oct;69(10):6389-99.

14.

Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.

Schulze A, Zerfass K, Spitkovsky D, Henglein B, Jansen-Dürr P.

Oncogene. 1994 Dec;9(12):3475-82.

PMID:
7970707
15.

Structure and cell cycle-regulated transcription of the human cyclin A gene.

Henglein B, Chenivesse X, Wang J, Eick D, Bréchot C.

Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5490-4.

16.

Loss of the G1-S control of cyclin A expression during tumoral progression of Chinese hamster lung fibroblasts.

Barlat I, Fesquet D, Bréchot C, Henglein B, Dupuy d'Angeac A, Vié A, Blanchard JM.

Cell Growth Differ. 1993 Feb;4(2):105-13.

17.

Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc.

Joos S, Haluska FG, Falk MH, Henglein B, Hameister H, Croce CM, Bornkamm GW.

Cancer Res. 1992 Dec 1;52(23):6547-52.

18.

Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.

Joos S, Falk MH, Lichter P, Haluska FG, Henglein B, Lenoir GM, Bornkamm GW.

Hum Mol Genet. 1992 Nov;1(8):625-32.

PMID:
1301171
19.

Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma.

Wang J, Zindy F, Chenivesse X, Lamas E, Henglein B, Bréchot C.

Oncogene. 1992 Aug;7(8):1653-6.

PMID:
1321406
20.

Cyclin A is required in S phase in normal epithelial cells.

Zindy F, Lamas E, Chenivesse X, Sobczak J, Wang J, Fesquet D, Henglein B, Bréchot C.

Biochem Biophys Res Commun. 1992 Feb 14;182(3):1144-54.

PMID:
1531751
21.

Assignment of a human cyclin A gene to 4q26-q27.

Blanquet V, Wang JA, Chenivesse X, Henglein B, Garreau F, Bréchot C, Turleau C.

Genomics. 1990 Nov;8(3):595-7. No abstract available.

PMID:
1962755
22.

Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours.

Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA.

Nature. 1990 Sep 20;347(6290):294-8.

PMID:
2205804
23.

Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma.

Wang J, Chenivesse X, Henglein B, Bréchot C.

Nature. 1990 Feb 8;343(6258):555-7.

PMID:
1967822
24.

t(2;8) variant translocation in Burkitt's lymphoma: mapping of chromosomal breakpoints by in situ hybridization.

Adolph S, Hameister H, Henglein B, Lipp M, Hartl P, Baas F, Lenoir G, Bornkamm GW.

Int J Cancer. 1989 Aug 15;44(2):261-5.

PMID:
2759731
25.

Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc.

Henglein B, Synovzik H, Groitl P, Bornkamm GW, Hartl P, Lipp M.

Mol Cell Biol. 1989 May;9(5):2105-13.

26.

Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma.

Shtivelman E, Henglein B, Groitl P, Lipp M, Bishop JM.

Proc Natl Acad Sci U S A. 1989 May;86(9):3257-60.

27.

Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma.

Ganser A, Carlo-Stella C, Bartram CR, Boehm T, Heil G, Henglein B, Müller H, Raghavachar A, von Briesen H, Griesinger F, et al.

Blood. 1988 Oct;72(4):1255-60.

PMID:
2844327
28.

Burkitt's lymphoma variant translocations: distribution of chromosomal breakpoints and perturbated regulation of a mutated c-myc gene.

Henglein B, Lipp M, Hartl P, Adolph S, Hameister H, Eick D, Polack A, Joos S, Baas F, Lenoir GM, et al.

Curr Top Microbiol Immunol. 1988;141:165-71. No abstract available.

PMID:
3215048
29.

Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives.

Eick D, Piechaczyk M, Henglein B, Blanchard JM, Traub B, Kofler E, Wiest S, Lenoir GM, Bornkamm GW.

EMBO J. 1985 Dec 30;4(13B):3717-25.

30.

c-myc and immunoglobulin kappa light chain constant genes are on the 8q+ chromosome of three Burkitt lymphoma lines with t(2;8) translocations.

Rappold GA, Hameister H, Cremer T, Adolph S, Henglein B, Freese UK, Lenoire GM, Bornkamm GW.

EMBO J. 1984 Dec 1;3(12):2951-5.

Supplemental Content

Loading ...
Support Center